Pacific Biosciences of California (PACB) Q4 2024 Annual Earnings
PACB·Reported February 13, 2025·After market close
Pacific Biosciences of California reported Q4 2024 revenue of $39.2M, missed analyst consensus of $40.7M by $1.5M. Diluted EPS came in at $-0.20.
Revenue
$39.2Mmissed by $1.5M
Consensus: $40.7MDiluted EPS
$-0.20met estimate
Consensus: $-0.20
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Pacific Biosciences of California's Q4 2024 earnings report.
Pacific Biosciences of California (PACB) reported Q4 2024 earnings on February 13, 2025 after market close.
Pacific Biosciences of California reported revenue of $39.2M and diluted EPS of $-0.20 for Q4 2024.
Revenue missed the consensus estimate of $40.7M by $1.5M. EPS beat the consensus estimate of $-0.20 by $0.00.
You can read the 10-K periodic report (0001299130-25-000061) directly on SEC EDGAR. The filing index links above go to sec.gov.